XRF SCIENTIFIC LIMITED — Director's Dealing 2025

Aug 21, 2025

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: XRF Scientific Limited ABN: 80 107 908 314

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Vance Stazzonelli
Date of last notice	26 May 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	a) Direct
	b) Indirect
Nature of indirect interest	Mr Vance Albert Stazzonelli <VS Investment A/C>
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevantinterest.	Mr Stazzonelli is a beneficiary of the trust
Date of change	21 August 2025
No. of securities held prior to change	a) Performance Rights = 803,153
	a) Ordinary Shares = Nil
	b) Ordinary Shares = 850,000
Class	a) Performance Rights & Ordinary Shares
	b) Ordinary Shares
Number acquired	a) Performance Rights = Nil
	a) Ordinary Shares = 384,088
	b) Ordinary Shares = Nil
Number disposed	a) Performance Rights = 384,088 (converted)
	a) Performance Rights = 18,415 (lapsed)
	a) Ordinary Shares = Nil
	b) Ordinary Shares = Nil
Value/Consideration	$810,426 (estimated value of ordinary shares
Note: If consideration is non-cash, provide details and estimatedvaluation	issued, based on 5-day VWAP of $2.11 per share)
No. of securities held after change	a) Performance Rights = 400,650
	a) Ordinary Shares = 384,088
	b) Ordinary Shares = 850,000

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Conversion of 384,088 Performance Rights into

Example: on-market trade, off-market trade, exercise of options, issue Ordinary Shares and lapsing of 18,415 of securities under dividend reinvestment plan, participation in buy-

back Performance Rights. The Performance Rights were originally issued in 2022.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation
Interest after change

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed abovetraded during a+closed period where prior written clearancewas required?	No
If so, was prior written clearance provided to allow the trade toproceed during this period?	N/A
If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011